Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

These 3 Drugs Are Critical to AbbVie's Success
Motley Fool
Mon, 02/12/18 - 09:10 am
Tags:
AbbVie, Rova-T, Upadacitinib, risankizumab
Watch These Biotechs and the FDA Calendar
TheStreet.com
Sun, 02/11/18 - 01:23 pm
Tags:
FDA, biotech, Dynavax, HEPLISAV-B, Progenics, Azedra, Neurocrine, Elagolix, AbbVie
ABBV to Focus on Advancing Late-Stage Immunology Research in 2018
Market Realist
Thu, 02/8/18 - 11:17 am
Tags:
AbbVie, R&D, immunology, Upadacitinib, risankizumab
Dogged by AbbVie's new share-stealing Mavyret, Gilead's hep C forecast comes in far short
Fierce Pharma
Thu, 02/8/18 - 09:14 am
Tags:
AbbVie, Mavyret, Gilead Sciences, hepatitis C, Harvoni, Sovaldi
AbbVie, Pfizer in another close TV ad spending race to kick off 2018
Fierce Pharma
Wed, 02/7/18 - 10:02 am
Tags:
AbbVie, Pfizer, drug ads, television ads
Biopharma in charts: Key takeaways from Q4 earnings
Biopharma Dive
Mon, 02/5/18 - 12:35 pm
Tags:
earnings, Merck, JNJ, AbbVie, Roche, Celgene, Eli Lilly
3 Big Biotech Stocks With Major Catalysts on the Way
Motley Fool
Tue, 01/30/18 - 09:50 am
Tags:
biotech, AbbVie, Neurocrine Biosciences, Elagolix, Celgene, ozanimod, Gilead Sciences, bictegravir
Why big pharma companies always create new spinoffs
GoinPharma
Sun, 01/28/18 - 10:06 am
Tags:
spinoffs, Sanofi, Celgene, Biogen, AbbVie, Abbott Labs, Baxalta, Shire
AbbVie wins U.S. trial in lawsuit over AndroGel's risks
Yahoo/Reuters
Sat, 01/27/18 - 09:38 am
Tags:
AbbVie, Androgel, pulmonary embolism
Why AbbVie (ABBV) Might Surprise This Earnings Season
Yahoo/Zacks.com
Thu, 01/25/18 - 09:33 am
Tags:
AbbVie, earnings
5 Highest-Growth Drugs of 2018 -- and Who Will Get Rich from Them
Motley Fool
Sun, 01/21/18 - 10:53 am
Tags:
Merck, Keytruda, AbbVie, Humira, Mavyret, Bristol-Myers Squibb, Eliquis, Pfizer, Ibrance
Novartis aims for US approval of Humira biosimilar
Biopharma Dive
Wed, 01/17/18 - 09:55 pm
Tags:
Novartis, Humira, biosimilars, AbbVie, Sandoz
Why AbbVie's Upadacitinib Keeps Posting Strong Data for Rheumatoid Arthritis
Market Realist
Mon, 01/8/18 - 09:42 am
Tags:
AbbVie, Upadacitinib, rheumatoid arthritis
2018 Healthcare And Biotech Outlook
Seeking Alpha
Sun, 01/7/18 - 12:41 pm
Tags:
AbbVie, Abbott Labs, Amgen, Allergan, AstraZeneca, Gilead Sciences, Bristol-Myers Squibb
5 Biggest New Drugs of 2018
Motley Fool
Sun, 01/7/18 - 12:35 pm
Tags:
Gilead Sciences, Bictegravir/F/TAF, Novo Nordisk, semaglutide, Ozempic, Incyte, epacadostat, AbbVie, Rova-T, Celgene, ozanimod
Pfizer, Novartis and more post price hikes on dozens of drugs, but AbbVie’s is worth the most
Fierce Pharma
Thu, 01/4/18 - 10:27 pm
Tags:
drug pricing, Pfizer, Novartis, AbbVie
Top 10 stories that had pharma execs talking
Biopharma Dive
Thu, 01/4/18 - 12:02 pm
Tags:
M&A, Bristol-Myers Squibb, Opdivo, Express Scripts, Novartis, C-ART, Kymriah, Massachusetts, AbbVie, Kenneth Frazier, biosimilars, CVS Health Pfizer
3 Best Big Pharma Stocks for 2018
Motley Fool
Tue, 01/2/18 - 11:06 am
Tags:
JNJ, Celgene, AbbVie
Here's How AbbVie Inc. Crushed It in 2017
Yahoo/Motley Fool
Tue, 12/26/17 - 09:48 am
Tags:
AbbVie, biosimilars, Humira, Imbruvica
Another death mars AbbVie’s latest batch of promising data for its star rheumatoid arthritis drug
BioPharma Dive
Wed, 12/20/17 - 11:42 am
Tags:
AbbVie, rheumatoid arthritis, Upadacitinib, ABT-494

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.